Business Context and Reporting Period
This Form 8-K Current Report was filed by Alector, Inc. on September 8, 2021. The filing addresses a material change in the company's executive leadership structure, specifically the appointment of an interim Chief Financial Officer.
Key Financial Metrics
The filing does not provide financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The only financial figure disclosed relates to the compensation arrangement for the new interim officer.
- Consulting Rate: $600 per hour for services provided by FLG Partners, LLC.
Material Changes
The primary material change reported is the appointment of Linda Rubinstein as Interim Chief Financial Officer, Principal Financial Officer, and Principal Accounting Officer, effective September 8, 2021. Concurrently, Mr. Calvin Yu ceased serving as Principal Financial Officer and Principal Accounting Officer but will remain as Vice President, Finance.
Management Commentary and Risks
Ms. Rubinstein, a partner at FLG Partners, LLC, brings over 30 years of experience in the life sciences sector. She will serve in her interim capacity until a successor is appointed or until her earlier resignation or removal. The company entered into a Confidential Consulting Agreement with FLG Partners, effective September 3, 2021. The full text of this agreement is not included in this filing but will be filed as an exhibit to the Form 10-Q for the quarter ended September 30, 2021.
Investor Verification Checklist
- Verify the terms of the Confidential Consulting Agreement with FLG Partners, LLC, which will be filed as an exhibit to the upcoming Form 10-Q.
- Monitor future filings for the appointment of a permanent Chief Financial Officer to replace the interim arrangement.
- Review the upcoming Form 10-Q for the fiscal quarter ended September 30, 2021, to assess the financial impact of the leadership transition and the company's overall financial health.